# FDA Inspection 1166014 - Holy Cross of Silver Spring Blood Bank - February 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/120e10fa-1f31-4705-a65d-b008d3f2c878
Source feed: FDA_Inspections

> FDA Inspection 1166014 for Holy Cross of Silver Spring Blood Bank on February 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166014
- Company Name: Holy Cross of Silver Spring Blood Bank
- Inspection Date: 2022-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253461 - 2024-10-22](https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/b21a6e5c-d93d-4a50-bbb3-e2d48f19b441)
- [FDA Inspection 1253461 - 2024-10-22](https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/06d81443-ba33-4814-a095-f9ee85be0d5f)
- [FDA Inspection 1166014 - 2022-02-28](https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/773f9d3b-ef28-49ff-a676-23cf2838753f)
- [FDA Inspection 1081239 - 2019-01-29](https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/9c1ef83e-eaee-4207-9db3-a375b2ba24da)
- [FDA Inspection 1014489 - 2017-05-25](https://www.keypedia.com/records/fda_inspections/holy-cross-of-silver-spring-blood-bank/d4d30f20-ebba-4fd8-b8e2-e847fa4b75cc)

Company: https://www.keypedia.com/companies/holy-cross-of-silver-spring-blood-bank/1dc04f6e-8f06-4a35-91b3-507299f97dd7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d